Materials & Resources » Chemicals | Sharon Bio-Medicine Ltd.

Sharon Bio-Medicine Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2011
2012
2013
2014
2016
2017
2018
Cash & Short Term Investments
39
63
63
123
102
-
-
Total Accounts Receivable
2,254
3,144
3,956
4,941
2,042
-
-
Inventories
1,552
1,962
2,602
3,225
1,800
-
-
Other Current Assets
-
-
-
-
7
-
-
Total Current Assets
3,845
5,169
6,622
8,289
3,951
-
-
Net Property, Plant & Equipment
2,079
2,612
3,144
3,399
3,186
-
-
Total Investments and Advances
32
33
33
6
1
-
-
Long-Term Note Receivable
-
-
-
-
-
-
-
Other Assets
-
-
-
-
91
-
-
Total Assets
5,957
7,815
9,799
11,695
7,228
-
-
ST Debt & Current Portion LT Debt
2,128
2,689
3,630
4,340
2,927
Accounts Payable
351
501
601
614
400
Income Tax Payable
40
91
120
130
-
Other Current Liabilities
35
73
34
64
49
Total Current Liabilities
2,555
3,354
4,385
5,148
3,377
Long-Term Debt
1,308
1,935
2,809
2,914
5,436
Provision for Risks & Charges
4
5
5
5
15
Deferred Taxes
47
70
83
105
215
Total Liabilities
3,914
5,365
7,282
8,172
9,043
Common Equity (Total)
2,043
2,450
2,517
3,523
1,815
Total Shareholders' Equity
2,043
2,450
2,517
3,523
1,815
Total Equity
2,043
2,450
2,517
3,523
1,815
Liabilities & Shareholders' Equity
5,957
7,815
9,799
11,695
7,228

About Sharon Bio-Medicine

View Profile
Address
601, Proxima, Plot No.19
Mumbai Maharashtra 400705
India
Employees -
Website http://www.sharonbio.com
Updated 07/08/2019
Sharon Bio-Medicine Ltd. engages in the manufacturing of pharmaceutical formulations and chemical intermediates. The company provides pharmaceutical products and services include: Animal toxicology and manufacturing of finished dosages. It offers preclinical toxicology, chemical process development & scale up, formulation development, analytical method development, DMF & dossier preparation, commercial manufacturing of intermediates, activities, finished dosages and stability monitoring for the entire shelf life of the product.